# Medsource Pharmaceuticals – FDA Inspection, Dec 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/medsource-pharmaceuticals/a04eb301-fc2c-4e12-b213-a81fbfb4ce00
Source feed: FDA_Inspections

> FDA inspection 1224701 of Medsource Pharmaceuticals, December 11, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224701
- Company Name: Medsource Pharmaceuticals
- Inspection Date: 2023-12-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1111872 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/medsource-pharmaceuticals/d491d5ce-3fe5-4de8-8e6d-e1d15ae892c4)
- [FDA Inspection 1009141 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/medsource-pharmaceuticals/22c0161c-f145-43d4-a42e-c39f4bdce90f)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lillian-s-wu/b1f6643c-ac01-43e5-8ce2-e6f4fdba9d35)

Company: https://www.keypedia.com/companies/medsource-pharmaceuticals/35015922-a2dd-4cc5-96b2-258f9c7b5260

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c